Literature DB >> 33127178

[Demodex and ocular surface disease].

W Ben Hadj Salah1, C Baudouin2, S Doan3, A Angoulvant4, J Gottlieb5, J Bénichou1, E Da Cunha1, L Eid1, M Labetoulle6, A Rousseau7.   

Abstract

Demodex is a saprophytic mite of the ocular adnexa, which can in certain circumstances proliferate on the skin of the face and on the eyelid margins. It is involved in facial rosacea (especially in the papulopustular form) and in the development or aggravation of anterior and/or posterior blepharitis or even keratoconjunctivitis, often in association with cutaneous lesions ; the pathophysiology is often multifactorial. Symptoms are non-specific, but the presence of cylindrical sleeves on the eyelashes is very suggestive of infestation, and certain techniques of biomicroscopic examination or imaging, such as confocal microscopy in vivo, allow direct visualization of the parasite. Parasitological examination of the eyelashes can confirm the diagnosis and can be improved by good sampling technique. Eyelid hygiene and oil-based ointments are the cornerstone of treatment. New specific treatments, in particular topical treatments based on tea tree oil, ivermectin, as well as pulsed light therapy and micro-exfoliation of the eyelid margin, can help to reduce the parasitic load and improve symptoms.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Blepharitis; Blépharite; Demodex; Dysfonction meibomienne; Huile d’arbre à thé; Ivermectin; Ivermectine; Meibomian gland dysfunction; Rosacea; Rosacée; Tea tree oil

Mesh:

Substances:

Year:  2020        PMID: 33127178     DOI: 10.1016/j.jfo.2020.08.002

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  A Survey on How Ocular Surface Demodex Infestation Interactively Associates with Diabetes Mellitus and Dry Eye Disease.

Authors:  Chang Huang; Shuze Chen; Sheng Fu; Yingli Li; Zhenhao Li; Siqi Li; Xiaoqian Liang; Zihong Wang; Zhoucheng Wang; Yifan Chen; Qixin Deng; Guoguo Yi; Min Fu
Journal:  Acta Parasitol       Date:  2021-04-03       Impact factor: 1.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.